Drawing for PYXIS GENOMICS

USPTO serial 78119620

PYXIS GENOMICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BUCHANAN WILL, NORA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PYXIS GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Harold J. Milstein

HAROLD J MILSTEIN HELLER EHRMAN WHITE & MCAULIFFE LLP275 MIDDLEFIELD RDMENLO PARK, CA 94025-3506UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and biochemicals, namely, precursors for in vitro genetic engineering; genetic testing systems and kits comprised primarily of reagents for scientific and/or research useABANDONED—
005Housemark for a full line of diagnostic preparations for clinical and/or medical laboratory use, pharmaceutical preparations for therapeutic purposes, vaccines for humans and animals and genetic testing systems and kits comprised primarily of reagents for clinical and/or medical laboratory useABANDONED—
042Product research and development for others in the fields of genomics, bioinformatics, and animal and human health applications; genetic, genomic and bioinformatic engineering and consultation services; genetic testing servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 13, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jan 13, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Dec 3, 2003ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Dec 3, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Dec 3, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Dec 3, 2003OP.DOPPOSITION DISMISSED NO. 999999—
Apr 9, 2003OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 17, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 19, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2002NPUBNOTICE OF PUBLICATION—
Sep 16, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2002MAILPAPER RECEIVED—
Aug 20, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2002TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance